Considering the regulation of the VEGF-A pathway by the HIF axis, we report here the results on the expression of HIF-1α, HIF-2α and VHL studied by immunohistochemistry in patients with RCC treated with sunitinib [105]. Here, HIF1A is linked to renal cell carcinoma.